INO: יחס מחיר לרווח Inovio Pharmaceuticals, Inc.
The price history of Inovio Pharmaceuticals (INO) on the GURU.Markets platform with the -2.30 indicator reflects the dynamics of a company that delegates primary testing and drug production to external partners while retaining exclusive patent rights. Inovio Pharmaceuticals develops advanced DNA therapy methods and creates innovative intradermal drug delivery systems. Management is currently shifting its strategic focus toward treating rare lung pathologies while navigating regulatory challenges.
פילוחים אנליטיים של חברת Inovio Pharmaceuticals
The P/E ratio determines the cost per unit of profit, allowing for an assessment of the premium paid for an asset relative to its income-generating capacity. The forward P/E dynamics of a company visualize market expectations for future business capitalization. Calculated levels are formed through the ratio of the market share price to net earnings per share. For Inovio Pharmaceuticals (INO), this indicator reflects the value of its proprietary DNA medicine platform and R&D expenditures.
